Related Experiment Videos
Drug-induced psoriasis. Recognition and management
N Tsankov1, I Angelova, J Kazandjieva
1Department of Dermatology, Medical University, Sofia, Bulgaria.
American Journal of Clinical Dermatology
|November 13, 2001
Summary
Certain medications can trigger or worsen psoriasis, a common skin condition. This review details common culprits like beta-blockers and lithium, aiding clinical management of drug-influenced psoriasis.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Psoriasis is a prevalent skin disorder where understanding disease triggers is crucial for patient management.
- Drug intake is a significant factor influencing psoriasis, potentially causing new lesions or exacerbating existing conditions.
Purpose of the Study:
- To review common causative agents for drug-induced, drug-triggered, or drug-aggravated psoriasis.
- To provide clinicians with information on latency periods, mechanisms, clinical findings, and management strategies for drug-influenced psoriasis.
Main Methods:
- Literature review focusing on therapeutic agents linked to psoriasis induction or exacerbation.
- Classification of drugs based on the strength of evidence for their causal relationship with psoriasis.
Main Results:
- Identifies key drug classes associated with psoriasis, including beta-blockers, lithium, synthetic antimalarials, NSAIDs, and tetracyclines.
- Discusses the varying degrees of evidence linking these agents to psoriasis development or worsening.
Conclusions:
- Clinicians must be aware of medications that can influence psoriasis.
- Understanding drug-induced psoriasis is essential for effective patient care and treatment modification.